HCA Healthcare (HCA) | Financial Analysis & Statements
HCA Healthcare Inc. Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
19.5B
Gross Profit
8.2B
41.90%
Operating Income
3.2B
16.29%
Net Income
2.2B
11.08%
EPS (Diluted)
$8.14
Balance Sheet Metrics
Total Assets
60.7B
Total Liabilities
63.5B
Shareholders Equity
-2.8B
Cash Flow Metrics
Operating Cash Flow
1.8B
Free Cash Flow
870.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
HCA Healthcare Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 75.6B | 70.6B | 65.0B | 60.2B | 58.8B |
| Cost of Goods Sold | 44.2B | 41.9B | 9.9B | 9.4B | 9.5B |
| Gross Profit | 31.4B | 28.7B | 55.1B | 50.9B | 49.3B |
| Gross Margin % | 41.5% | 40.6% | 84.8% | 84.4% | 83.9% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | - | 31.2B | 29.5B | 27.7B | 26.8B |
| Other Operating Expenses | 15.9B | 14.8B | 12.9B | 11.2B | 10.0B |
| Total Operating Expenses | 15.9B | 46.0B | 42.4B | 38.8B | 36.7B |
| Operating Income | 12.0B | 10.5B | 9.6B | 9.1B | 9.7B |
| Operating Margin % | 15.8% | 14.9% | 14.8% | 15.0% | 16.5% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 2.2B | 2.1B | 1.9B | 1.7B | 1.6B |
| Other Non-Operating Income | 115.0M | 37.0M | 17.0M | 1.3B | 1.7B |
| Pre-tax Income | 9.8B | 8.5B | 7.7B | 8.6B | 9.8B |
| Income Tax | 2.0B | 1.9B | 1.6B | 1.7B | 2.1B |
| Effective Tax Rate % | 20.9% | 21.9% | 21.0% | 20.3% | 21.5% |
| Net Income | 7.8B | 6.7B | 6.1B | 6.8B | 7.7B |
| Net Margin % | 10.3% | 9.4% | 9.4% | 11.3% | 13.1% |
| Key Metrics | |||||
| EBITDA | 15.6B | 13.9B | 12.7B | 12.1B | 12.6B |
| EPS (Basic) | $30.20 | $23.04 | $19.25 | $19.43 | $22.77 |
| EPS (Diluted) | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 |
| Basic Shares Outstanding | 224605100 | 249981400 | 272404000 | 290348000 | 305476800 |
| Diluted Shares Outstanding | 224605100 | 249981400 | 272404000 | 290348000 | 305476800 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
HCA Healthcare Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 1.0B | 1.9B | 935.0M | 908.0M | 1.5B |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 10.9B | 10.8B | 10.0B | 8.9B | 8.1B |
| Inventory | 1.7B | 1.7B | 2.0B | 2.1B | 2.0B |
| Other Current Assets | 2.2B | 2.0B | 2.0B | 1.8B | 2.0B |
| Total Current Assets | 15.8B | 16.4B | 14.9B | 13.6B | 13.5B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 39.1B | 36.8B | 34.2B | 32.0B | 30.4B |
| Goodwill | 10.3B | 10.1B | 9.9B | 9.7B | 9.5B |
| Intangible Assets | - | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 255.0M | 230.0M | 184.0M | 298.0M | 598.0M |
| Total Non-Current Assets | 44.9B | 43.1B | 41.3B | 38.8B | 37.2B |
| Total Assets | 60.7B | 59.5B | 56.2B | 52.4B | 50.7B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 4.7B | 4.3B | 4.2B | 4.2B | 4.1B |
| Short-term Debt | 5.2B | 5.0B | 2.8B | 734.0M | 629.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 16.4B | 15.2B | 12.7B | 9.9B | 9.6B |
| Non-Current Liabilities | |||||
| Long-term Debt | 43.5B | 40.2B | 39.1B | 39.5B | 36.1B |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 3.7B | 3.6B | 1.6B | 1.5B | 1.5B |
| Total Non-Current Liabilities | 47.1B | 43.8B | 42.5B | 42.6B | 39.7B |
| Total Liabilities | 63.5B | 59.0B | 55.2B | 52.5B | 49.3B |
| Equity | |||||
| Common Stock | 2.0M | 3.0M | 3.0M | 3.0M | 3.0M |
| Retained Earnings | -5.7B | -2.1B | -1.4B | -2.3B | -532.0M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | -2.8B | 555.0M | 1.1B | -73.0M | 1.5B |
| Key Metrics | |||||
| Total Debt | 48.7B | 45.2B | 41.9B | 40.2B | 36.7B |
| Working Capital | -567.0M | 1.2B | 2.3B | 3.7B | 4.0B |
Balance Sheet Composition
HCA Healthcare Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 7.8B | 6.7B | 6.1B | 6.8B | 7.7B |
| Depreciation & Amortization | 3.5B | 3.3B | 3.1B | 3.0B | 2.9B |
| Stock-Based Compensation | 401.0M | 360.0M | 262.0M | 341.0M | 440.0M |
| Working Capital Changes | -248.0M | -465.0M | -1.1B | -856.0M | -1.5B |
| Operating Cash Flow | 12.0B | 10.2B | 8.8B | 10.0B | 9.6B |
| Investing Activities | |||||
| Capital Expenditures | -4.9B | -4.9B | -4.7B | -4.4B | -3.6B |
| Acquisitions | -128.0M | 62.0M | -442.0M | 1.0B | 1.1B |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -5.1B | -4.8B | -5.2B | -3.4B | -2.5B |
| Financing Activities | |||||
| Share Repurchases | -10.1B | -6.0B | -3.8B | -7.0B | -8.2B |
| Dividends Paid | -679.0M | -690.0M | -661.0M | -653.0M | -624.0M |
| Debt Issuance | 8.5B | 7.5B | 3.2B | 6.0B | 4.3B |
| Debt Repayment | -7.4B | -4.3B | -909.0M | -2.8B | -3.9B |
| Financing Cash Flow | -8.6B | -4.6B | -4.1B | -5.7B | -6.7B |
| Free Cash Flow | 7.7B | 5.6B | 4.7B | 4.1B | 5.4B |
| Net Change in Cash | -1.6B | 769.0M | -477.0M | 982.0M | 387.0M |
Cash Flow Trend
HCA Healthcare Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
16.86
Forward P/E
14.13
Price to Book
-38.44
Price to Sales
1.39
PEG Ratio
0.37
Profitability Ratios
Profit Margin
8.97%
Operating Margin
16.29%
Return on Equity
-244.82%
Return on Assets
12.44%
Financial Health
Current Ratio
0.96
Debt to Equity
-17.57
Beta
1.37
Per Share Data
EPS (TTM)
$27.94
Book Value per Share
$-26.83
Revenue per Share
$319.78
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| HCA | 106.0B | 16.86 | -38.44 | -244.82% | 8.97% | -17.57 |
| Tenet Healthcare | 16.5B | 12.17 | 3.88 | 27.02% | 6.60% | 160.79 |
| Universal Health | 11.1B | 7.84 | 1.52 | 21.33% | 8.57% | 69.73 |
| Ensign Group | 11.1B | 32.78 | 4.95 | 16.90% | 6.80% | 98.70 |
| Encompass Health | 10.2B | 18.52 | 4.21 | 24.82% | 9.54% | 82.85 |
| DaVita | 10.0B | 16.32 | 9.13 | 64.85% | 5.47% | 1,111.35 |
Financial data is updated regularly. All figures are in the company's reporting currency.






